Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.

Journal of acquired immune deficiency syndromes (1999) - 1 Sept 2005

Napravnik Sonia, Edwards David, Stewart Paul, Stalzer Brant, Matteson Elizabeth, Eron Joseph J

Abstract excerpt

Many patients infected with HIV do not achieve or maintain virologic suppression below levels of detection while on potent combination antiretroviral therapy. The likelihood of emergence of incident mutations conferring reduced antiretroviral drug susceptibility was estimated among patients maintained on a stable regimen with ongoing detectable plasma HIV RNA levels. Ninety-eight HIV-infected patients were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Biological Evolution

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to HIV Infections

Share to Regression Analysis

Share to Viremia

Source

Identifiers

PMID: 16123679
DOI: 10.1097/01.qai.0000174929.87015.d6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.PMID 16123679Read ↗

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.Semantic proximity Read ↗

Genotypic Analysis of HIV‐1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV LoadsSemantic proximity Read ↗

HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.Semantic proximity Read ↗

Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations.Semantic proximity Read ↗

In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.Semantic proximity Read ↗

Persistence of primary drug resistance among recently HIV-1 infected adults.Semantic proximity Read ↗

Antiretroviral resistance during successful therapy of HIV type 1 infection.Semantic proximity Read ↗

Recent trends in HIV-1 drug resistanceSemantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.Semantic proximity Read ↗

Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated, HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment RegimenSemantic proximity Read ↗

Persistence of HIV-1 Transmitted Drug Resistance MutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.